Log In
Print
BCIQ
Print
Print this Print this
 

Brivanib (BMS-582664)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionDual inhibitor of VEGFR-2 and fibroblast growth factor (FGF) receptor 1 (FGFR1; CD331)
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2) ; Fibroblast growth factor (FGF) receptor 1 (FGFR1) (CD331)
Mechanism of ActionFibroblast growth factor (FGF) receptor (FGFR) agonist; Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) kinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today